Literature DB >> 16849328

pfmdr2 confers heavy metal resistance to Plasmodium falciparum.

Elli Rosenberg1, Ilena Litus, Nurit Schwarzfuchs, Rosa Sinay, Pnina Schlesinger, Jacob Golenser, Stefan Baumeister, Klaus Lingelbach, Yaakov Pollack.   

Abstract

Heavy metals are required by all organisms for normal function, but high levels of heavy metals are toxic. Therefore, homeostasis of these metals is crucial. In the human malaria-causing agent Plasmodium falciparum, the mechanisms of heavy metal transport have yet to be characterized. We have developed a P. falciparum line resistant to heavy metals from a wild-type line sensitive to heavy metals. A molecular and biochemical analysis of the involvement of the P. falciparum multidrug resistance 2 (pfmdr2) gene, an ABC-type transporter, in heavy metal homeostasis was studied. Using a novel uptake assay applied on these two strains, it was demonstrated that, when exposed to heavy metals, the sensitive line accumulates metal, whereas no accumulation was observed in the resistant line. The accumulation occurs within the parasite itself and not in the cytoplasm of the red blood cell. This difference in the accumulation pattern is not a result of amplification of the pfmdr2 gene or of a change in the expression pattern of the gene in the two lines. Sequencing of the gene from both lines revealed a major difference; a stop codon is found in the sensitive line upstream of the normal termination, resulting in a truncated protein that lacks 188 amino acids that contain a portion of the essential cytoplasmatic transporter domain, thereby rendering it inactive. In contrast, the resistant line harbors a full-length, active protein. These findings strongly suggest that the PFMDR2 protein acts as an efflux pump of heavy metals.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16849328     DOI: 10.1074/jbc.M601686200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  The F423Y mutation in the pfmdr2 gene and mutations N51I, C59R, and S108N in the pfdhfr gene are independently associated with pyrimethamine resistance in Plasmodium falciparum isolates.

Authors:  Sébastien Briolant; Hervé Bogreau; Marine Gil; Housem Bouchiba; Eric Baret; Rémy Amalvict; Christophe Rogier; Bruno Pradines
Journal:  Antimicrob Agents Chemother       Date:  2012-02-06       Impact factor: 5.191

2.  Genome scanning of Amazonian Plasmodium falciparum shows subtelomeric instability and clindamycin-resistant parasites.

Authors:  Neekesh V Dharia; David Plouffe; Selina E R Bopp; Gonzalo E González-Páez; Carmen Lucas; Carola Salas; Valeria Soberon; Badry Bursulaya; Tadeusz J Kochel; David J Bacon; Elizabeth A Winzeler
Journal:  Genome Res       Date:  2010-09-09       Impact factor: 9.043

3.  Differential, positional-dependent transcriptional response of antigenic variation (var) genes to biological stress in Plasmodium falciparum.

Authors:  Elli Rosenberg; Amir Ben-Shmuel; Oshrit Shalev; Rosa Sinay; Alan Cowman; Yaakov Pollack
Journal:  PLoS One       Date:  2009-09-10       Impact factor: 3.240

4.  Study on association between genetic polymorphisms of haem oxygenase-1, tumour necrosis factor, cadmium exposure and malaria pathogenicity and severity.

Authors:  Jiraporn Kuesap; Kenji Hirayama; Mihoko Kikuchi; Ronnatrai Ruangweerayut; Kesara Na-Bangchang
Journal:  Malar J       Date:  2010-09-17       Impact factor: 2.979

5.  A class of tricyclic compounds blocking malaria parasite oocyst development and transmission.

Authors:  Richard T Eastman; Sittiporn Pattaradilokrat; Dipak K Raj; Saurabh Dixit; Bingbing Deng; Kazutoyo Miura; Jing Yuan; Takeshi Q Tanaka; Ronald L Johnson; Hongying Jiang; Ruili Huang; Kim C Williamson; Lynn E Lambert; Carole Long; Christopher P Austin; Yimin Wu; Xin-Zhuan Su
Journal:  Antimicrob Agents Chemother       Date:  2012-11-05       Impact factor: 5.191

6.  Genetic architecture of artemisinin-resistant Plasmodium falciparum.

Authors:  Olivo Miotto; Roberto Amato; Elizabeth A Ashley; Bronwyn MacInnis; Jacob Almagro-Garcia; Chanaki Amaratunga; Pharath Lim; Daniel Mead; Samuel O Oyola; Mehul Dhorda; Mallika Imwong; Charles Woodrow; Magnus Manske; Jim Stalker; Eleanor Drury; Susana Campino; Lucas Amenga-Etego; Thuy-Nhien Nguyen Thanh; Hien Tinh Tran; Pascal Ringwald; Delia Bethell; Francois Nosten; Aung Pyae Phyo; Sasithon Pukrittayakamee; Kesinee Chotivanich; Char Meng Chuor; Chea Nguon; Seila Suon; Sokunthea Sreng; Paul N Newton; Mayfong Mayxay; Maniphone Khanthavong; Bouasy Hongvanthong; Ye Htut; Kay Thwe Han; Myat Phone Kyaw; Md Abul Faiz; Caterina I Fanello; Marie Onyamboko; Olugbenga A Mokuolu; Christopher G Jacob; Shannon Takala-Harrison; Christopher V Plowe; Nicholas P Day; Arjen M Dondorp; Chris C A Spencer; Gilean McVean; Rick M Fairhurst; Nicholas J White; Dominic P Kwiatkowski
Journal:  Nat Genet       Date:  2015-01-19       Impact factor: 38.330

7.  Whole genome re-sequencing identifies a mutation in an ABC transporter (mdr2) in a Plasmodium chabaudi clone with altered susceptibility to antifolate drugs.

Authors:  Axel Martinelli; Gisela Henriques; Pedro Cravo; Paul Hunt
Journal:  Int J Parasitol       Date:  2010-09-19       Impact factor: 3.981

8.  Localization of the ATP-binding cassette (ABC) transport proteins PfMRP1, PfMRP2, and PfMDR5 at the Plasmodium falciparum plasma membrane.

Authors:  Reginald A Kavishe; Jeroen M W van den Heuvel; Marga van de Vegte-Bolmer; Adrian J F Luty; Frans G M Russel; Jan B Koenderink
Journal:  Malar J       Date:  2009-08-28       Impact factor: 2.979

9.  A Plasmodium falciparum copper-binding membrane protein with copper transport motifs.

Authors:  David L Choveaux; Jude M Przyborski; J P Dean Goldring
Journal:  Malar J       Date:  2012-11-29       Impact factor: 2.979

10.  Dual fluorescent labelling of the human malaria parasite Plasmodium falciparum for the analysis of the ABC type transporter pfmdr2.

Authors:  Benyamin Rosental; Uzi Hadad; Rosa Sinay; Alex Braiman; Angel Porgador; Yaakov Pollack
Journal:  Malar J       Date:  2012-11-08       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.